At a glance
ClinicalIndex Comparison RecordN/ACompleted· 118 enrolled
Drug / intervention
Toronto EVLP System™device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Multicenter, Open-label Study to Measure the Safety of Extending Preservation and Assessment Time of Donor Lungs Using Normothermic Ex Vivo Lung Perfusion and Ventilation (EVLP) as Administered by the SPONSOR Using the Toronto EVLP System™
In Brief
A clinical study evaluating Toronto EVLP System™ for Lung Disease. Completed, enrolled 118 participants across 8 sites.
Detailed Summary
This is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against standard lung transplantation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 2014
Enrollment StartJul 2015
Primary CompletionNov 2018
Study CompletionNov 2019
TodayJul 2026
First PostedSep 9, 2014
Enrollment StartJul 18, 2015
Primary CompletionNov 21, 2018
Study CompletionNov 7, 2019
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 11.8 years ago
Interventions
Toronto EVLP System™device
Extending preservation and assessment time of donor lungs using the Toronto EVLP System